Maximizing Poison Potential: Advisory
Panel Calls for Flu Vaccine for Everybody
If you thought only those at risk for of complications should
get a yearly flu shot, think again. According to the corrupt officials
of the Center For Disease Control's (CDC) advisory panel, everybody
should get the flu shot.
The CDC almost certainly will make universal flu vaccination
official U.S. policy for this fall's 2010-2011 flu season, as
it consistently follows the advice of the panel representatives
with strong ties to the pharmaceutical industry such as the Advisory
Committee on Immunization Practices (ACIP).
Flu vaccinations will now be advised even for healthy adults
ages 19 to 49 who are who are not at highest risk of flu complications
and do not come into contact with infants or elderly people.
That's only 15% of the U.S. population. But the ACIP say the
effect of the universal recommendation will target far more people.
That's because the 19-49 age range will mean more profits and
potentially more complications from vaccines which can also lead
to even further pharmaceutical intervention.
Under the guise of simplifying confusing guidelines and convincing
the public that insurers will cover the flu shots, the panel is
using these and other deceptive strategies to promote the universal
ACIP members also said that the universal recommendation would
assure Americans that the nation's public health experts (or biggest
drug pushers) are fully confident in the safety and effectiveness
of the flu vaccine -- particularly the H1N1 swine flu vaccine.
If you believe that, I have a nice water front property in the
desert to sell you.
vaccines are never tested in humans before they are produced
to scale. It doesn't matter what type of flu vaccine it is...it
is categorically impossible to test a flu vaccine before it is
mass produced on the scale that flu vaccines are manufactured
today. It takes several years for most vaccines to move from preclinical
development to the marketplace.
Before a vaccine enters human testing, the developer conducts
laboratory (in vitro) and laboratory animal (in vivo) testing
to determine whether the product will be safe enough for researchers
to proceed to clinical trials. If a flu vaccine were to follow
the standard development procedures, by the time it would actually
enter the marketplace it would be useless, since the strain it
was testing against during clinical development has now changed.
This is the nature of vaccine development versus flu viruses and
something the vaccine industrial complex will never admit to.
The 2010-2011 seasonal flu vaccine will include
the H1N1 swine flu virus to ensure a broader segment of population
is exposed to the form of the virus. This will maximize the virus'
ability to change its receptor bindings, recombine and become
far more lethal than its present form. This will also ensure a
higher case fatality rate and a much higher rate of infection.
As hard as it may be to believe, that is the goal.
Dave Mihalovic is a Naturopathic Doctor who specializes in
vaccine research, cancer prevention and a natural approach to
February 26, 2010